Treatment of Depression in Acute Coronary Syndromes with Selective Serotonin Reuptake Inhibitors

被引：0
|
作者：
Joost P. van Melle
Peter de Jonge
Maarten P. van den Berg
Harm J. Pot
Dirk J. van Veldhuisen
机构：
[1] University Medical Center Groningen,Department of Cardiology, Thoraxcenter
[2] University of Groningen,Department of Internal Medicine and Psychiatry
[3] University Medical Center Groningen,Department of Psychiatry
[4] University of Groningen,undefined
[5] University Medical Center Groningen,undefined
[6] University of Groningen,undefined
来源：
Drugs | 2006年 / 66卷
关键词：
Acute Coronary Syndrome; Heart Rate Variability; Fluoxetine; Paroxetine; Sertraline;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Depression in patients with acute coronary syndromes (ACS) is common and associated with impaired cardiovascular prognosis in terms of cardiac mortality and new cardiovascular events. It remains unclear whether antidepressant treatment may reverse these effects. In this review, the literature is evaluated on (i) the antidepressant efficacy of selective serotonin reuptake inhibitors (SSRIs) for depression in patients with ACS; (ii) the pleiomorphic effects of SSRIs that may be associated with cardiovascular prognosis; and (iii) the effects of SSRIs on cardiovascular prognosis.
引用
收藏
页码：2095 / 2107
页数：12
相关论文
共 50 条
  • [31] Use of selective serotonin-reuptake inhibitors in the treatment of depression in adults with HIV
    Caballero, J
    Nahata, MC
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (01) : 141 - 145
  • [32] Juvenile depression treatment with antidepressants from the selective serotonin reuptake inhibitors group
    Suleymanov, Ramil F.
    Gorenkov, Roman V.
    Chernus, Natalya P.
    Orlov, Sergey A.
    Kalinina, Irina F.
    BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2019, 18 (03): : 615 - 623
  • [33] Serotonin-selective reuptake inhibitors in the treatment of geriatric depression and related disorders
    Mulchahey, JJ
    Malik, MS
    Sabai, M
    Kasckow, JW
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 1999, 2 (02): : 121 - 127
  • [34] Selective serotonin reuptake inhibitors in adolescent depression still controversial
    Holzer, Laurent
    Baumann, Pierre
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (03) : 325 - 326
  • [35] Treating depression with selective serotonin reuptake inhibitors: A practical approach
    Sampson, SM
    MAYO CLINIC PROCEEDINGS, 2001, 76 (07) : 739 - 744
  • [36] The economics of selective serotonin reuptake inhibitors in depression - A critical review
    Frank, L
    Revicki, DA
    Sorensen, SV
    Shih, YCT
    CNS DRUGS, 2001, 15 (01) : 59 - 83
  • [37] Pharmacogenetics of selective serotonin reuptake inhibitors in pediatric depression and anxiety
    Kronenberg, Sefi
    Frisch, Amos
    Rotberg, Beni
    Carmel, Miri
    Apter, Alan
    Weizman, Abraham
    PHARMACOGENOMICS, 2008, 9 (11) : 1725 - 1736
  • [38] Use of selective serotonin reuptake inhibitors in childhood depression - Reply
    Whittington, CJ
    Kendall, T
    Fonagy, P
    Cottrell, D
    Cotgrove, A
    LANCET, 2004, 364 (9435): : 661 - 661
  • [39] Selective serotonin reuptake inhibitors and vasopressin: an intersection of depression and preeclampsia
    Vignato, Julie
    Scroggins, Sabrina
    Brandt, Debra
    Thomas, Kellie
    Santillan, Donna
    Santillan, Mark
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : S99 - S99
  • [40] Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors
    Nair, GV
    Gurbel, PA
    O'Connor, CM
    Gattis, WA
    Murugesan, SR
    Serebruany, VL
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (03): : 321 - +
12345